L
6.81
-0.05 (-0.73%)
| Previous Close | 6.86 |
| Open | 6.85 |
| Volume | 4,946,367 |
| Avg. Volume (3M) | 1,726,638 |
| Market Cap | 2,605,662,720 |
| Price / Earnings (Forward) | 119.05 |
| Price / Sales | 2.31 |
| Price / Book | 1.91 |
| 52 Weeks Range | |
| Earnings Date | 8 Aug 2024 |
| Profit Margin | -13.05% |
| Operating Margin (TTM) | -5.01% |
| Diluted EPS (TTM) | -0.410 |
| Quarterly Revenue Growth (YOY) | 20.30% |
| Total Debt/Equity (MRQ) | 34.78% |
| Current Ratio (MRQ) | 1.22 |
| Operating Cash Flow (TTM) | 13.66 M |
| Levered Free Cash Flow (TTM) | 86.73 M |
| Return on Assets (TTM) | -2.25% |
| Return on Equity (TTM) | -10.32% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Care Facilities (US) | Bullish | Mixed |
| Medical Care Facilities (Global) | Bullish | Mixed | |
| Stock | LifeStance Health Group, Inc. | Bearish | Bearish |
Stockmoo Score
-0.9
| Analyst Consensus | -3.5 |
| Insider Activity | NA |
| Price Volatility | -2.0 |
| Technical Moving Averages | 0.0 |
| Technical Oscillators | 2.0 |
| Average | -0.88 |
|
LifeStance Health Group Inc is a mental healthcare company focused on providing evidence-based, medically driven treatment services for children, adolescents, and adults suffering from a variety of mental health issues in an outpatient care setting, both in-person and through its digital health telemedicine offering. |
|
| Sector | Healthcare |
| Industry | Medical Care Facilities |
| Investment Style | Small Core |
| % Held by Insiders | 11.11% |
| % Held by Institutions | 91.07% |
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 7.50 (UBS, 10.13%) | Hold |
| Median | 6.75 (-0.88%) | |
| Low | 6.00 (Barclays, -11.89%) | Sell |
| Average | 6.75 (-0.88%) | |
| Total | 1 Hold, 1 Sell | |
| Avg. Price @ Call | 5.72 | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| UBS | 15 Aug 2024 | 7.50 (10.13%) | Hold | 5.84 |
| Barclays | 09 Aug 2024 | 6.00 (-11.89%) | Sell | 5.60 |
No data within this time range.
| Date | Type | Details |
|---|---|---|
| 08 Oct 2024 | Announcement | LifeStance Survey Finds 79% of Americans Are Experiencing Anxiety Over the 2024 U.S. Presidential Election |
| 21 Aug 2024 | Announcement | LifeStance to Present at the 22nd Annual Morgan Stanley Healthcare Conference |
| 08 Aug 2024 | Announcement | LifeStance Reports Second Quarter 2024 Results |
| 01 Aug 2024 | Announcement | LifeStance Survey Finds US Adults Prioritize Access to Therapy Over Free Taylor Swift Tickets and Vacations |
| 18 Jul 2024 | Announcement | LifeStance to Host Second Quarter 2024 Earnings Conference Call on August 8, 2024 |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2024 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |